Beyond the Bottleneck: A Leap in Automated Cell Line Engineering

10:00 AM - 10:45 AM ET | 4:00 PM - 4:45 PM CET

Nov 6, 2025

About the Webinar

Join us for an exclusive webinar with bit.bio and CYTENA as we explore a revolutionary leap in cell line development. A major bottleneck in the cell line engineering field has been the use of manual single-colony isolation of engineered iPSCs.

Here, bit.bio is introducing how they integrated the UP.SIGHT single-cell dispenser into their cellular engineering platform to overcome this bottleneck through automation, increasing both throughput and accuracy.

In this webinar, you will learn how:

  • Collaborative expertise between bit.bio and CYTENA has produced high-efficiency protocols
  • The optimized workflow has increased throughput and precision while providing double assurance of clonality
  • This strategic implementation is setting the stage for scalable, next-generation cell line engineering from leaders in the field at bit.bio

Don’t miss this opportunity to transform your lab’s workflow!

Register now and secure your spot to unlock the future of cell line engineering from leaders in the field at bit.bio

Presenters & Moderators

Adam Hill bitbio

Adam Hill

Scientist
bit.bio

Pierre-Henri Ferdinand CYTENA Headshot

Pierre-Henri Ferdinand

Product Manager CLD
CYTENA

Trusted By 1000s
Of Your Peers At
Premier Research
Labs Worldwide

Happy customers in 6 continents.
This does not happen by accident.

Peerless: In Quality and
Customer Support

Global
Market Leader

Pioneers of the single-cell dispensing category

Made
in Germany

Engineered with Uncompromising Quality

Onsite Service
& Support

Europe, UK, USA, Singapore, South Korea and Japan

World
Class Expertise

Years of History of Success and Growth

Let’s Create
The Future Of Health

Revolutionize your cell line development workflow across multiple research areas. Focus on your research as our dispenser ensures precision and efficiency, making it the perfect tool for both complex experiments and simple assays. Experience the future of cell line development today.